|
US9012141B2
(en)
|
2000-03-27 |
2015-04-21 |
Advaxis, Inc. |
Compositions and methods comprising KLK3 of FOLH1 antigen
|
|
US7695725B2
(en)
*
|
2003-02-06 |
2010-04-13 |
Aduro Biotech |
Modified free-living microbes, vaccine compositions and methods of use thereof
|
|
WO2004084936A2
(en)
*
|
2003-02-06 |
2004-10-07 |
Cerus Corporation |
Modified free-living microbes, vaccine compositions and methods of use thereof
|
|
JP4545151B2
(ja)
|
2003-02-06 |
2010-09-15 |
シーラス コーポレイション |
非食細胞中への侵入について減弱化されているリステリア、そのリステリアを含むワクチン、およびそれらの使用法
|
|
JP2006524693A
(ja)
*
|
2003-04-11 |
2006-11-02 |
メディミューン，インコーポレーテッド |
ＥｐｈＡ２および非腫瘍性過増殖性細胞障害
|
|
US7842289B2
(en)
|
2003-12-24 |
2010-11-30 |
Aduro Biotech |
Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof
|
|
WO2006034334A2
(en)
|
2004-09-21 |
2006-03-30 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Peptide analogs capable of enhancing stimulation of a glioma-specific ctl response
|
|
CA2584130A1
(en)
*
|
2004-10-18 |
2006-04-27 |
Medimmune, Inc. |
High cell density process for growth of listeria
|
|
AU2005299354A1
(en)
*
|
2004-10-27 |
2006-05-04 |
Medimmune, Llc |
Modulators of EphA2 and ephrina1 for the treatment of fibrosis-related disease
|
|
DE102006004612A1
(de)
*
|
2006-02-01 |
2007-08-16 |
Ralf Dr. med. Jochem |
Therapeutische Zusammensetzung zur Vorbeugung und Bekämpfung von Knochenmetastasen
|
|
JP5347135B2
(ja)
|
2006-03-01 |
2013-11-20 |
アドゥロ バイオテック |
遺伝子工学操作されたｌｉｓｔｅｒｉａおよびその使用方法
|
|
US7935804B2
(en)
|
2006-03-01 |
2011-05-03 |
Aduro Biotech |
Engineered Listeria and methods of use thereof
|
|
US20070207171A1
(en)
*
|
2006-03-01 |
2007-09-06 |
Cerus Corporation |
Engineered listeria and methods of use thereof
|
|
WO2007103261A2
(en)
*
|
2006-03-01 |
2007-09-13 |
Medimmune, Inc. |
Listeria-based epha2 immunogenic compositions
|
|
US8926993B2
(en)
|
2006-07-17 |
2015-01-06 |
Aduro Biotech |
Methods and compositions using Listeria for enhancing immunogenicity by prime boost
|
|
US8241636B2
(en)
|
2006-08-15 |
2012-08-14 |
The Trustees Of The University Of Pennsylvania |
Compositions comprising HMW-MAA and fragments thereof, and methods of use thereof
|
|
US8268326B2
(en)
|
2006-08-15 |
2012-09-18 |
The Trustees Of The University Of Pennsylvania |
Compositions comprising HMW-MAA and fragments thereof, and methods of use thereof
|
|
WO2009028639A1
(ja)
|
2007-08-30 |
2009-03-05 |
Daiichi Sankyo Company, Limited |
抗ｅｐｈａ２抗体
|
|
WO2009044272A2
(en)
*
|
2007-10-04 |
2009-04-09 |
000'npt Mbp Gormezis' |
Laser-based vaccine adjuvants
|
|
US9650639B2
(en)
|
2008-05-19 |
2017-05-16 |
Advaxis, Inc. |
Dual delivery system for heterologous antigens
|
|
WO2009143167A2
(en)
|
2008-05-19 |
2009-11-26 |
Advaxis |
Dual delivery system for heterologous antigens
|
|
US9017660B2
(en)
*
|
2009-11-11 |
2015-04-28 |
Advaxis, Inc. |
Compositions and methods for prevention of escape mutation in the treatment of Her2/neu over-expressing tumors
|
|
US20140234370A1
(en)
*
|
2009-11-11 |
2014-08-21 |
Advaxis, Inc. |
Compositions and methods for prevention of escape mutation in the treatment of her2/neu over-expressing tumors
|
|
CA2724649A1
(en)
|
2008-05-19 |
2009-11-26 |
Anza Therapeutics, Inc. |
Compositions comprising prfa* mutant listeria and methods of use thereof
|
|
WO2010071769A2
(en)
*
|
2008-12-12 |
2010-06-24 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. |
Chimeric l. monocytogens in1b protein
|
|
JP5539411B2
(ja)
|
2009-03-04 |
2014-07-02 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
血管新生因子を含む組成物およびその使用方法
|
|
WO2011060260A2
(en)
*
|
2009-11-11 |
2011-05-19 |
Advaxis |
Compositions and methods for prevention of escape mutation in the treatment of her2/neu over-expressing tumors
|
|
US10016617B2
(en)
|
2009-11-11 |
2018-07-10 |
The Trustees Of The University Of Pennsylvania |
Combination immuno therapy and radiotherapy for the treatment of Her-2-positive cancers
|
|
KR20130056855A
(ko)
|
2010-03-01 |
2013-05-30 |
카리스 라이프 사이언스 룩셈부르크 홀딩스 |
치료진단용 생물학적 지표들
|
|
KR20130043104A
(ko)
|
2010-04-06 |
2013-04-29 |
카리스 라이프 사이언스 룩셈부르크 홀딩스 |
질병용 순환 생물학적 지표들
|
|
ES2613630T3
(es)
|
2010-05-23 |
2017-05-25 |
Aduro Biotech, Inc. |
Métodos y composiciones que utilizan Listeria para un tratamiento auxiliar del cáncer
|
|
GB2482536B
(en)
|
2010-08-05 |
2013-07-24 |
Hera Pharmaceuticals Inc |
Expression of antibody or a fragment thereof in lactobacillus
|
|
WO2012027379A2
(en)
|
2010-08-24 |
2012-03-01 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Interleukin-13 receptor alpha 2 peptide-based brain cancer vaccines
|
|
CN107412756A
(zh)
|
2010-10-01 |
2017-12-01 |
宾夕法尼亚大学理事会 |
李斯特菌疫苗载体用于在寄生虫感染的个体中扭转免疫无应答的用途
|
|
EP2446895A1
(en)
*
|
2010-10-01 |
2012-05-02 |
Stemgen S.P.A. |
EPH receptor expression in tumor stem cells
|
|
WO2012125551A1
(en)
|
2011-03-11 |
2012-09-20 |
Advaxis |
Listeria-based adjuvants
|
|
AU2012318590B2
(en)
|
2011-10-04 |
2017-05-18 |
Expression Pathology, Inc. |
SRM/MRM assay for the ephrin type-A receptor 2 protein
|
|
SG10201700392UA
(en)
|
2012-03-12 |
2017-03-30 |
Advaxis Inc |
Suppressor cell function inhibition following listeria vaccine treatment
|
|
SMT202100545T1
(it)
|
2012-05-16 |
2021-11-12 |
Stemline Therapeutics Inc |
Vaccini contro il cancro mirati alle cellule staminali cancerose
|
|
JP6257607B2
(ja)
|
2012-06-08 |
2018-01-10 |
アデュロ バイオテック，インコーポレイテッド |
癌免疫療法のための組成物および方法
|
|
CA2888678A1
(en)
|
2012-11-06 |
2014-05-15 |
Aduro Biotech, Inc. |
Facultatively attenuated bacterial species and methods of preparation and use thereof
|
|
MX361680B
(es)
|
2012-12-13 |
2018-12-13 |
Aduro Biotech Inc |
Composiciones que comprenden dinucleótidos de purina cíclicos que tienen estereoquímicas definidas y métodos para su preparación y uso.
|
|
SG11201502792TA
(en)
|
2012-12-27 |
2015-05-28 |
Aduro Biotech Inc |
Signal peptide fusion partners facilitating listerial expression of antigenic sequences and methods of preparation and use thereof
|
|
JP2016518140A
(ja)
|
2013-05-03 |
2016-06-23 |
ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア |
Ｉ型インターフェロンの環状ジヌクレオチド誘導法
|
|
US9549944B2
(en)
|
2013-05-18 |
2017-01-24 |
Aduro Biotech, Inc. |
Compositions and methods for inhibiting “stimulator of interferon gene”—dependent signalling
|
|
ES2754269T3
(es)
|
2013-05-18 |
2020-04-16 |
Aduro Biotech Inc |
Composiciones y métodos de activación de la señalización dependiente del "estimulador de los genes de interferón
|
|
JP2017514904A
(ja)
*
|
2014-05-02 |
2017-06-08 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
Ｈｅｒ２陽性ガンの治療のための免疫療法および放射線療法の併用
|
|
WO2016061115A1
(en)
|
2014-10-13 |
2016-04-21 |
Providence Health & Services-Oregon D/B/A Providence Portland Medical Center |
Bacterial vaccines deficient in the 2-c-methyl-d-erythritol-4-phosphate pathway and methods of preparation and use thereof
|
|
SG11201702857PA
(en)
*
|
2014-10-14 |
2017-05-30 |
Univ Pennsylvania |
Recombinant listeria vaccine strains and methods of using the same in cancer immunotherapy
|
|
EP3215139B1
(en)
|
2014-11-03 |
2020-08-19 |
Cerus Corporation |
Compositions and methods for improved car-t cell therapies
|
|
US10676723B2
(en)
|
2015-05-11 |
2020-06-09 |
David Gordon Bermudes |
Chimeric protein toxins for expression by therapeutic bacteria
|
|
CA2990864A1
(en)
|
2015-06-26 |
2016-12-29 |
Cerus Corporation |
Cryoprecipitate compositions and methods of preparation thereof
|
|
WO2017070619A1
(en)
|
2015-10-23 |
2017-04-27 |
Cerus Corporation |
Plasma compositions and methods of use thereof
|
|
NL2017267B1
(en)
|
2016-07-29 |
2018-02-01 |
Aduro Biotech Holdings Europe B V |
Anti-pd-1 antibodies
|
|
NL2017270B1
(en)
|
2016-08-02 |
2018-02-09 |
Aduro Biotech Holdings Europe B V |
New anti-hCTLA-4 antibodies
|
|
US11180535B1
(en)
|
2016-12-07 |
2021-11-23 |
David Gordon Bermudes |
Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
|
|
AU2017382449B2
(en)
|
2016-12-23 |
2024-10-24 |
Cerus Corporation |
Systems and methods for testing and screening using compound bound substrates
|
|
CA3055203A1
(en)
|
2017-03-03 |
2018-09-07 |
Cerus Corporation |
Kits and methods for preparing pathogen-inactivated platelet compositions
|
|
WO2019133929A1
(en)
|
2017-12-29 |
2019-07-04 |
Cerus Corporation |
Systems and methods for treating biological fluids
|
|
WO2020263759A2
(en)
|
2019-06-22 |
2020-12-30 |
Cerus Corporation |
Biological fluid treatment systems
|
|
US12514944B2
(en)
|
2019-06-22 |
2026-01-06 |
Cerus Corporation |
Systems and methods for implementing treatment of biological fluids
|
|
AU2020308035B2
(en)
|
2019-06-28 |
2025-07-24 |
Cerus Corporation |
System and methods for implementing a biological fluid treatment device
|
|
CN114015644A
(zh)
*
|
2021-11-05 |
2022-02-08 |
成都生物制品研究所有限责任公司 |
一种单一病毒收获液的生产方法
|
|
CN114848654B
(zh)
*
|
2022-04-18 |
2024-04-05 |
武汉大学 |
阿司匹林在制备用于引起肿瘤免疫原性细胞死亡的药物中的应用
|